Overview
This interview provides a thorough description of hepatocellular carcinoma (HCC) treatment in the US.
All targeted therapies available for HCC treatment are discussed, as well as a discussion of Phase III pipeline drugs and the potential impact these therapies would have if they gain approval.
This interview provides a thorough description of hepatocellular carcinoma (HCC) treatment in the US.
All targeted therapies available for HCC treatment are discussed, as well as a discussion of Phase III pipeline drugs and the potential impact these therapies would have if they gain approval.
